OBJECTIVE: Schlager hypertensive (BPH/2J) mice have been suggested to have high blood pressure (BP) due to an overactive sympathetic nervous system (SNS), but the contribution of the renin-angiotensin system (RAS) is unclear. In the present study, we examined the cardiovascular effects of chronically blocking the RAS in BPH/2J mice. METHODS: Schlager normotensive (BPN/3J, n = 6) and BPH/2J mice (n = 8) received the angiotensin AT 1A-receptor antagonist losartan (150 mg/kg per day) in drinking water for 2 weeks. Pre-implanted telemetry devices were used to record mean arterial pressure (MAP), heart rate (HR) and locomotor activity. RESULTS: MAP was reduced by losartan treatment in BPN/3J (-23 mmHg, P < 0.01) and in BPH/2J mice (-25 mmHg, P < 0.001), whereas HR was increased. Losartan had little effect on initial pressor responses to feeding or to stress, but did attenuate the sustained pressor response to cage-switch stress. During the active period, the hypotension to sympathetic blockade with pentolinium was greater in BPH/2J than BPN/3J (suggesting neurogenic hypertension), but was not affected by losartan. During the inactive period, a greater depressor response to pentolinium was observed in losartan-treated animals. CONCLUSION: The hypotensive actions of losartan suggest that although the RAS provides an important contribution to BP, it contributes little, if at all, to the hypertension-induced or the greater stress-induced pressor responses in Schlager mice. The effects of pentolinium suggest that the SNS is mainly responsible for hypertension in BPH/2J mice. However, the RAS inhibits sympathetic vasomotor tone during inactivity and prolongs sympathetic activation during periods of adverse stress, indicating an important sympatho-modulatory role.
OBJECTIVE: Schlager hypertensive (BPH/2J) mice have been suggested to have high blood pressure (BP) due to an overactive sympathetic nervous system (SNS), but the contribution of the renin-angiotensin system (RAS) is unclear. In the present study, we examined the cardiovascular effects of chronically blocking the RAS in BPH/2J mice. METHODS: Schlager normotensive (BPN/3J, n = 6) and BPH/2J mice (n = 8) received the angiotensin AT 1A-receptor antagonist losartan (150 mg/kg per day) in drinking water for 2 weeks. Pre-implanted telemetry devices were used to record mean arterial pressure (MAP), heart rate (HR) and locomotor activity. RESULTS: MAP was reduced by losartan treatment in BPN/3J (-23 mmHg, P < 0.01) and in BPH/2J mice (-25 mmHg, P < 0.001), whereas HR was increased. Losartan had little effect on initial pressor responses to feeding or to stress, but did attenuate the sustained pressor response to cage-switch stress. During the active period, the hypotension to sympathetic blockade with pentolinium was greater in BPH/2J than BPN/3J (suggesting neurogenic hypertension), but was not affected by losartan. During the inactive period, a greater depressor response to pentolinium was observed in losartan-treated animals. CONCLUSION: The hypotensive actions of losartan suggest that although the RAS provides an important contribution to BP, it contributes little, if at all, to the hypertension-induced or the greater stress-induced pressor responses in Schlager mice. The effects of pentolinium suggest that the SNS is mainly responsible for hypertension in BPH/2J mice. However, the RAS inhibits sympathetic vasomotor tone during inactivity and prolongs sympathetic activation during periods of adverse stress, indicating an important sympatho-modulatory role.
Authors: Miranda E Good; Yu-Hsin Chiu; Ivan K H Poon; Christopher B Medina; Joshua T Butcher; Suresh K Mendu; Leon J DeLalio; Alexander W Lohman; Norbert Leitinger; Eugene Barrett; Ulrike M Lorenz; Bimal N Desai; Iris Z Jaffe; Douglas A Bayliss; Brant E Isakson; Kodi S Ravichandran Journal: Circ Res Date: 2017-12-13 Impact factor: 17.367
Authors: Elena Tutunea-Fatan; Khaled S Abd-Elrahman; Jean-Francois Thibodeau; Chet E Holterman; Brian J Holleran; Richard Leduc; Christopher R J Kennedy; Robert Gros; Stephen S G Ferguson Journal: Sci Rep Date: 2018-07-30 Impact factor: 4.379
Authors: Kristy L Jackson; Geoffrey A Head; Cindy Gueguen; Emily R Stevenson; Kyungjoon Lim; Francine Z Marques Journal: Front Physiol Date: 2019-10-18 Impact factor: 4.566
Authors: SarahRose Hall; Nicholas D Ward; Raj Patel; Armaan Amin-Javaheri; Hayes Lanford; R Tyler Grespin; Christine Couch; Ying Xiong; Rupak Mukherjee; Jeffrey A Jones; Jean Marie Ruddy Journal: JVS Vasc Sci Date: 2021-07-24
Authors: Jonathan W Nelson; Mohammed Z Ferdaus; James A McCormick; Jessica Minnier; Sanjiv Kaul; David H Ellison; Anthony P Barnes Journal: Physiol Genomics Date: 2018-01-08 Impact factor: 3.107
Authors: Kristy L Jackson; Francine Z Marques; Kyungjoon Lim; Pamela J Davern; Geoffrey A Head Journal: Front Physiol Date: 2018-03-19 Impact factor: 4.566